Navitor Pharmaceuticals Is A Biopharmaceutical Company Based In Cambridgemassachusettsfounded In 2009 Or 2010The Company Specializes In Developing Therapeutics That Target Cellular Nutrient Signaling Pathwaysparticularly The Mtorc1 Pathwaythis Focus Aims To Address Various Diseases Linked To Mtorc1 Dysregulationincluding Metabolicneurodegenerativeautoimmunemusculoskeletaland Rare Disorders Navitor S Proprietary Platform Develops Small Molecule Drugs Designed To Selectively Regulate Mtorc1Key Candidates Include Nv 5138An Orally Active Mtorc1 Activator Currently In Phase 2 Trials For Treatment Resistant Depressive Disorderand Nv 20494An Early Stage Candidate In Phase 1 Targeting Autosomal Dominant Polycystic Kidney Diseasethe Company Has Established Partnershipsincluding A Development Agreement With Supernus Pharmaceuticals To Advance Nv 5138And Has A Leadership Team With Significant Expertise In The Field
No conferences found for this company.
| Company Name | Navitor Pharmaceuticals Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
